109 results
DEFA14A
TCRX
Tscan Therapeutics Inc
30 Apr 24
Additional proxy soliciting materials
4:10pm
Gruia, M.D. 02 Barbara Klencke, M.D. 2 To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm
424B5
TCRX
Tscan Therapeutics Inc
17 Apr 24
Prospectus supplement for primary offering
9:58pm
. These activities may raise or maintain the market price of the common stock above independent market levels or prevent or retard a decline in the market price … and instruments. The underwriters and their respective affiliates may also make investment recommendations or publish or express independent research
8-K
EX-5.1
TCRX
Tscan Therapeutics Inc
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
below. We have relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinion set
8-K
EX-1.1
6bywfyq49tws
17 Apr 24
TScan Therapeutics Announces Launch of $125 million Proposed
6:25am
424B5
72imf6jj320fmpe01
16 Apr 24
Prospectus supplement for primary offering
5:21pm
S-8
EX-5.1
ou1 tnbnnic06
6 Mar 24
Registration of securities for employees
4:05pm
S-8
EX-23.1
9k2nt1zc49m13cjg
6 Mar 24
Registration of securities for employees
4:05pm
S-8
45suk
6 Mar 24
Registration of securities for employees
4:05pm
8-K
EX-99.2
dwg1asx94wm6vf8uk
11 Dec 23
Regulation FD Disclosure
8:00am